Procos SpA: API manufacturing

Your End-to-End Partner in Niche APIs, from Lab to Global Markets

Your Partner for Niche APIs for Global Markets

A wholly owned subsidiary of CBC Group, Procos S.p.A. is our dedicated facility for development, scale-up, and GMP manufacturing of APIs and advanced intermediates.

A wholly owned subsidiary of CBC Group, Procos S.p.A. is our dedicated for development, scale-up, and GMP manufacturing of APIs and advanced intermediates.

Innovation Rooted in API Manufacturing Excellence

CBC’s API manufacturing capabilities are led by Procos S.p.A., our wholly owned Italian subsidiary, Specializing in the development, scale-up, and production of

Procos serves innovators, generic manufacturers, and global CDMO clients with equal precision. 

With operations deeply rooted in scientific innovation and regulatory compliance, we provide tailor-made solutions for complex development and commercial manufacturing needs, serving customers across Europe, Asia, and global regulated markets.

Manufacturing Excellence for Smarter Solutions

Our 155,000 sq. meter manufacturing site, located in Cameri, Italy, is a cGMP-compliant, multipurpose facility audited and approved by major global regulatory authorities, including the USFDA, AIFA, and PMDA.

Every capability is powered by specialized teams of PhDs, chemists, engineers, and regulatory experts, working seamlessly across R&D, QA, QC, IP, Regulatory, Procurement, and Manufacturing functions.

Global Expertise in API Manufacturing

At CBC, through our wholly owned subsidiary Procos S.p.A. we serve as an agile, quality-focused partner across the pharmaceutical value chain. From early-stage development to commercial-scale production, our integrated capabilities span custom synthesis, generic API manufacturing, and R&D-driven process innovation.

1. Custom Synthesis

We offer full CDMO services from early-stage development to clinical trial supplies and commercial production. Our project teams integrate with clients to provide:

  • Route scouting and process development
  • Analytical and process validation
  • Regulatory affairs support and dossier readiness

Transparent collaboration across R&D, QA, and production teams

Our generics portfolio includes 50+ APIs across diverse therapeutic areas, developed using IP-safe synthesis routes. We support partners with:

  • Non-infringing process development by in-house IP experts
  • Comprehensive regulatory documentation (DMFs, CoAs, GMP, etc.)
  • Supply chain assurance through qualified procurement teams
  • Global delivery with strong commercial and sales infrastructure
At the heart of Procos is a dedicated R&D team that brings together academic excellence with real-world execution. We focus on:
  • Optimization and rapid scale-up of lab processes
  • Use of robotic tools like CHEMSPEED® for data precision
  • Implementation of Flow Chemistry and safe process controls
  • Analytical method development using advanced instrumentation
  • Strong expertise in Para-IV development

Procos: The Future of Pharma

At Procos, development and manufacturing are approached as a single, continuous responsibility. Processes are designed with scale, validation, and long-term supply in mind from the outset, reducing transfer risk and ensuring consistency from early development through commercialization.

Scale with Confidence. Manufacture with Precision.

From lab-scale innovation to global commercial supply, CBC India and Procos offer world-class API manufacturing with regulatory compliance and technical depth at every step.